These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
76 related items for PubMed ID: 7502907
1. Clonal antibody dominance after influenza vaccination in IgA nephropathy patients and controls. Radl J, Hoogeveen CM, van den Wall Bake AW, Mestecky J. Adv Exp Med Biol; 1995; 371B():829-34. PubMed ID: 7502907 [No Abstract] [Full Text] [Related]
2. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza. Maeda A, Oishi I, Minekawa Y, Kunita N, Funahashi S, Yagura H. Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537 [No Abstract] [Full Text] [Related]
3. Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination. de Bruijn IA, Remarque EJ, Jol-van der Zijde CM, van Tol MJ, Westendorp RG, Knook DL. J Infect Dis; 1999 Jan; 179(1):31-6. PubMed ID: 9841819 [Abstract] [Full Text] [Related]
4. Characteristic of humoral response of elderly to inactivated influenza vaccine. Siennicka J. Arch Immunol Ther Exp (Warsz); 1996 Jan; 44(5-6):389-94. PubMed ID: 9017157 [Abstract] [Full Text] [Related]
5. In vivo antibody response to mucosal (NASAL) and subcutaneous stimulation of influenza virus in patients with IgA nephropathy. Kashem A, Endoh M, Yano N, Yamauchi F, Nomoto Y, Sakai H. Tokai J Exp Clin Med; 1992 May; 17(1):23-8. PubMed ID: 1523689 [Abstract] [Full Text] [Related]
6. Pandemic H1N1 influenza virus-like particles are immunogenic and provide protective immunity to pigs. Pyo HM, Masic A, Woldeab N, Embury-Hyatt C, Lin L, Shin YK, Song JY, Babiuk S, Zhou Y. Vaccine; 2012 Feb 08; 30(7):1297-304. PubMed ID: 22207090 [Abstract] [Full Text] [Related]
7. Parenteral influenza vaccination induces a rapid systemic and local immune response. Brokstad KA, Cox RJ, Olofsson J, Jonsson R, Haaheim LR. J Infect Dis; 1995 Jan 08; 171(1):198-203. PubMed ID: 7798664 [Abstract] [Full Text] [Related]
8. Serological response to whole, split and subunit influenza vaccines of persons with and without immunological experience towards influenza A/U.S.S.R. 90/77 virus. Sarateanu DE, Ehrengut W, Pressler K, Peukert M, Schenk KD. Comp Immunol Microbiol Infect Dis; 1980 Jan 08; 3(1-2):225-36. PubMed ID: 7471712 [No Abstract] [Full Text] [Related]
9. [Postvaccinal anti-influenza immunity and its determining factors]. Kastrikina LN, Lonskaia NI. Vopr Virusol; 1990 Jan 08; 35(5):362-7. PubMed ID: 2267774 [No Abstract] [Full Text] [Related]
10. Antibody responses to influenza vaccines containing A/New Jersey/8/76. Feery BJ, Hampson AW, Rodda SJ, Evered MG. Aust J Exp Biol Med Sci; 1978 Dec 08; 56(6):639-47. PubMed ID: 752306 [Abstract] [Full Text] [Related]
11. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees. Kilbourne ED, Cerini CP, Khan MW, Mitchell JW, Ogra PL. J Immunol; 1987 May 01; 138(9):3010-3. PubMed ID: 3571981 [Abstract] [Full Text] [Related]
12. Increase of in vivo and in vitro production of polyclonal IgA in patients and their family members with IgA nephropathy. Sakai H, Nomoto Y, Tomino Y, Endoh M, Miura M, Suga T. Adv Exp Med Biol; 1987 May 01; 216B():1507-14. PubMed ID: 3122535 [No Abstract] [Full Text] [Related]
13. Immune response to oral polio vaccine in patients with IgA glomerulonephritis. Leinikki PO, Mustonen J, Pasternack A. Clin Exp Immunol; 1987 Apr 01; 68(1):33-8. PubMed ID: 2820631 [Abstract] [Full Text] [Related]
14. [Studies on anti-neuraminidase antibody response in serum after inoculation of influenza hemagglutinin vaccines]. Hiromatsu Y, Sato Y, Inoguchi T, Umeno H, Kurosawa Y, Ishii K, Kobayashi K, Kaji M, Shingu T, Hayashida K. Kansenshogaku Zasshi; 1984 May 01; 58(5):367-75. PubMed ID: 6434660 [No Abstract] [Full Text] [Related]
15. Vaccination of an adolescent group with A (H3N2) + A(HSW1N1) bivaccine before an A (H1N1) influenza epidemic. Stumpa A, Cihla F, Tůmová B, Husek V, Slezácek J. Acta Virol; 1979 Sep 01; 23(5):443-5. PubMed ID: 42307 [Abstract] [Full Text] [Related]
16. [Formation and protective functions of antibodies to neuraminidase of the influenza A virus]. Naĭkhin AN, Tsaritsyna IM, Oleĭnikova EV, Ismagulov AT, Reznik VI. Vopr Virusol; 1985 Sep 01; 30(1):35-9. PubMed ID: 3993000 [Abstract] [Full Text] [Related]
17. [Basic characteristics of a live influenza vaccine for children from type A influenza (H1N1 and H3N2) used separately and in combination]. Rudenko LG, Shvartsman IaS, Ispolatova AV, Grigor'eva EP, Drinevskiĭ VP. Vopr Virusol; 1989 Sep 01; 34(1):29-34. PubMed ID: 2728404 [Abstract] [Full Text] [Related]
18. [Formation and persistence of antibodies against envelope antigens of influenza virus after vaccination by formolized monovaccine (author's transl)]. Stumpa A, Bruj J, Tůmová B, Skocil V. Cesk Epidemiol Mikrobiol Imunol; 1978 Feb 01; 27(1):29-37. PubMed ID: 149598 [No Abstract] [Full Text] [Related]
19. Live tissue culture influenza vaccine for oral administration. I. Specific immune response to monovaccine A (H3N2) in volunteers. Alekseeva AK, Andzhaparidze OG, Gracheva EN, Sidorova LA, Melnikova SK. Acta Virol; 1979 Jan 01; 23(1):59-66. PubMed ID: 35960 [Abstract] [Full Text] [Related]
20. [Circulating and secretory antibodies in mice after administration of influenza virus by various routes]. Wilczyński J, Loza-Tulimowska M, Semkow R. Med Dosw Mikrobiol; 1979 Jan 01; 31(4):239-44. PubMed ID: 544981 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]